West Pharmaceutical Services (WST) 51.35 $WST
West to Host Fourth Quarter and Full Year 2014 Conference Call
Marketwired - Thu Feb 12, 3:10PM CST
West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2014 financial results before the market opens on Thursday, February 19, 2015 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-474-9505 (U.S.) or 857-244-7558 (International). The passcode is 21690107.
WST: 51.35 (+0.57)
West Launches High-Quality Flip-Off® PlusRU Seals
PR Newswire - Wed Feb 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of a new sterile drug vial seal, the Flip-Off® PlusRU seal. Part of West's Flip-Off® seal product family, these new ready-to-use seals help pharmaceutical and biopharmaceutical manufacturers protect the safety and integrity of their drug products while meeting regulatory requirements for increased drug cleanliness and safety.
WST: 51.35 (+0.57)
West Pharmaceutical: Wide Moat Company With Multiple Growth Drivers
Mark Lin - at Seeking Alpha - Tue Jan 20, 12:54PM CST
WST: 51.35 (+0.57)
How it All Plays Out: Special Research on Verso, Vulcan Materials, Grace, Wausau and West Pharma
PR Newswire - Thu Jan 15, 7:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Verso (NYSE: VRS), Vulcan Materials (NYSE: VMC), Grace (NYSE: GRA), Wausau (NYSE: WPP), and West Pharma (NYSE: WST). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
WST: 51.35 (+0.57), GRA: 101.61 (+1.69), VMC: 79.87 (+0.46), VRS: 2.23 (unch), WPP: 9.80 (+0.10)
West to Present at Upcoming Investor Conference
Marketwired - Fri Jan 09, 6:38PM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 33rd Annual J.P. Morgan Healthcare Conference, San Francisco, CA at 8:00 a.m. PT on Thursday, January 15th, 2015.
WST: 51.35 (+0.57), JPM: 59.67 (+0.10)
Tracking The Sequoia Fund - Q3 2014
V is for Value - at Seeking Alpha - Tue Jan 06, 1:05PM CST
SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), VRX: 167.00 (-0.50), PRGO: 150.90 (+0.22), AAP: 150.16 (-1.26), WMT: 85.81 (-0.08), CNQ: 31.63 (+0.45), DHR: 86.81 (+0.21), PCP: 205.54 (+1.37), GOOG: 549.01 (+6.08), FAST: 42.50 (+0.26), TRMB: 26.86 (-0.40), INT: 53.72 (+2.28), IBM: 160.40 (+1.88), COST: 147.10 (-0.66), GOOGL: 551.16 (+5.15), EME: 43.70 (+0.61), MA: 87.14 (-0.38), JEC: 43.27 (+0.71), ORLY: 205.55 (-1.02), TIF: 89.05 (+0.95), WAT: 119.86 (+0.71), ZTS: 45.46 (-0.33), OMC: 77.56 (+1.09), BRO: 33.01 (+0.20), VRSK: 67.90 (+0.46), GS: 189.00 (-0.78), TJX: 69.24 (+0.36), MHK: 173.00 (+1.08), EXPD: 45.81 (+0.49), RBA: 26.71 (+0.16), IDXX: 159.08 (+1.72), PX: 126.89 (+1.53), BRK.B: 148.34 (-1.45), BRK.A: 222,555.00 (-1,905.00)
20.5% Return Seen to Date on SmarTrend West Pharmaceutical Services Call (WST)
Comtex SmarTrend(R) - Tue Jan 06, 11:13AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 5 months, West Pharmaceutical Services has returned 20.49% as of today's recent price of $51.17.
WST: 51.35 (+0.57)
11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015
at The Street - Fri Jan 02, 1:43PM CST
Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.
ACHC: 63.20 (-0.45), SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), USPH: 41.08 (+0.07), ATRI: 332.77 (-2.85), STE: 65.50 (-0.35), GB: 50.86 (+0.20), TFX: 112.07 (+0.47), ICLR: 60.01 (+0.38), CMN: 44.28 (+1.09), UTMD: 58.02 (-0.40)
West Pharmaceutical Services Up 27.8% Since SmarTrend Uptrend Call (WST)
Comtex SmarTrend(R) - Mon Dec 29, 9:46AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 4 months, West Pharmaceutical Services has returned 27.76% as of today's recent price of $54.26.
WST: 51.35 (+0.57)
West Pharmaceutical declares $0.11 dividend
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 11:34AM CST
WST: 51.35 (+0.57)
CORRECTION - West Announces Quarterly Dividend
Marketwired - Mon Dec 22, 11:11AM CST
In the news release issued Friday, December 19, 2014 by West Pharmaceutical Services, Inc. (NYSE: WST), we are advised by the company that the originally issued headline was incorrect. Complete corrected text follows.
WST: 51.35 (+0.57)
West Pharmaceutical Services Has Returned 28.9% Since SmarTrend Recommendation (WST)
Comtex SmarTrend(R) - Mon Dec 22, 9:15AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 4 months, West Pharmaceutical Services has returned 28.94% as of today's recent price of $54.76.
WST: 51.35 (+0.57)
West reports hike of 10% in quarterly dividend
M2 - Mon Dec 22, 5:52AM CST
The board of directors of West Pharmaceutical Services (NYSE:WST), a healthcare company, declared on Friday its dividend of USD0.11 per share for the Q1 2015.
WST: 51.35 (+0.57)
West Announces 10% Increase in Quarterly Dividend
Marketwired - Fri Dec 19, 3:30PM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2015 dividend of $0.11 per share. The dividend will be paid on February 4, 2015 to shareholders of record as of January 21, 2015.
WST: 51.35 (+0.57)
Shares of WST Up 25.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 12, 4:48PM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 4 months, West Pharmaceutical Services has returned 25.62% as of today's recent price of $53.35.
WST: 51.35 (+0.57)
Dividend Contenders, Future Champions Or Future Failures: Part 9
Stan Stafford - at Seeking Alpha - Thu Dec 11, 8:26PM CST
WST: 51.35 (+0.57), ATRI: 332.77 (-2.85), MLAB: 73.79 (-1.37)
Why Are These Four Stock Groups On The Rise?
at Investor's Business Daily - Wed Dec 10, 10:36AM CST
Momentum can shift quickly on Wall Street. A single trend or event sends some stocks or industries tumbling, while others get a shot in the arm and race higher. Stock groups that fall into the latter category -- share prices that have spiked...
FDX: 176.47 (+0.17), WST: 51.35 (+0.57), BDX: 143.71 (+0.72), PDCO: 50.65 (-0.16), DIS: 104.17 (+0.59), AIRT: 19.45 (+0.39), UPS: 101.79 (+0.38), TWX: 83.87 (+0.56), NFLX: 466.10 (+9.37), WHR: 213.23 (+0.18), AAWW: 48.01 (+0.44), VIA: 69.08 (+1.02), NWL: 39.57 (+0.32), CFN: 59.81 (+0.01), MIDD: 105.62 (+1.51), FOXA: 34.72 (+0.31), CBS: 59.83 (+2.06)
Eternity Healthcare receives US FDA's approval for NovaGuard SA for safer administration of vaccines
M2 - Wed Dec 10, 6:22AM CST
Medical diagnostic company Eternity Healthcare (Other OTC:ETAH) reported on Tuesday the receipt of the Food and Drug Administration's (FDA) 510(K) clearance to start producing Needle-stick Guards to help the medical professionals administer vaccines in a safer way.
WST: 51.35 (+0.57)
FDA Approves a Safer Way to Administer Vaccines
GlobeNewswire - Tue Dec 09, 8:11AM CST
Eternity Healthcare Inc. (OTC:ETAH), a medical device and diagnostic company with advanced technologies in Needle-Free Injection system, announced today that the Food and Drug Administration (FDA) has given 510(K) clearance to West Pharmaceutical Services, Inc. to start producing Needle-stick Guards to help the Medical Professionals administer vaccines in a safer way.
WST: 51.35 (+0.57)
West to Host Fourth Quarter and Full Year 2014 Conference Call
Marketwired - Thu Feb 12, 3:10PM CST
West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2014 financial results before the market opens on Thursday, February 19, 2015 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-474-9505 (U.S.) or 857-244-7558 (International). The passcode is 21690107.
WST: 51.35 (+0.57)
West Launches High-Quality Flip-Off® PlusRU Seals
PR Newswire - Wed Feb 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of a new sterile drug vial seal, the Flip-Off® PlusRU seal. Part of West's Flip-Off® seal product family, these new ready-to-use seals help pharmaceutical and biopharmaceutical manufacturers protect the safety and integrity of their drug products while meeting regulatory requirements for increased drug cleanliness and safety.
WST: 51.35 (+0.57)
West Pharmaceutical: Wide Moat Company With Multiple Growth Drivers
Mark Lin - at Seeking Alpha - Tue Jan 20, 12:54PM CST
WST: 51.35 (+0.57)
How it All Plays Out: Special Research on Verso, Vulcan Materials, Grace, Wausau and West Pharma
PR Newswire - Thu Jan 15, 7:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Verso (NYSE: VRS), Vulcan Materials (NYSE: VMC), Grace (NYSE: GRA), Wausau (NYSE: WPP), and West Pharma (NYSE: WST). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
WST: 51.35 (+0.57), GRA: 101.61 (+1.69), VMC: 79.87 (+0.46), VRS: 2.23 (unch), WPP: 9.80 (+0.10)
West to Present at Upcoming Investor Conference
Marketwired - Fri Jan 09, 6:38PM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 33rd Annual J.P. Morgan Healthcare Conference, San Francisco, CA at 8:00 a.m. PT on Thursday, January 15th, 2015.
WST: 51.35 (+0.57), JPM: 59.67 (+0.10)
Tracking The Sequoia Fund - Q3 2014
V is for Value - at Seeking Alpha - Tue Jan 06, 1:05PM CST
SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), VRX: 167.00 (-0.50), PRGO: 150.90 (+0.22), AAP: 150.16 (-1.26), WMT: 85.81 (-0.08), CNQ: 31.63 (+0.45), DHR: 86.81 (+0.21), PCP: 205.54 (+1.37), GOOG: 549.01 (+6.08), FAST: 42.50 (+0.26), TRMB: 26.86 (-0.40), INT: 53.72 (+2.28), IBM: 160.40 (+1.88), COST: 147.10 (-0.66), GOOGL: 551.16 (+5.15), EME: 43.70 (+0.61), MA: 87.14 (-0.38), JEC: 43.27 (+0.71), ORLY: 205.55 (-1.02), TIF: 89.05 (+0.95), WAT: 119.86 (+0.71), ZTS: 45.46 (-0.33), OMC: 77.56 (+1.09), BRO: 33.01 (+0.20), VRSK: 67.90 (+0.46), GS: 189.00 (-0.78), TJX: 69.24 (+0.36), MHK: 173.00 (+1.08), EXPD: 45.81 (+0.49), RBA: 26.71 (+0.16), IDXX: 159.08 (+1.72), PX: 126.89 (+1.53), BRK.B: 148.34 (-1.45), BRK.A: 222,555.00 (-1,905.00)
20.5% Return Seen to Date on SmarTrend West Pharmaceutical Services Call (WST)
Comtex SmarTrend(R) - Tue Jan 06, 11:13AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 5 months, West Pharmaceutical Services has returned 20.49% as of today's recent price of $51.17.
WST: 51.35 (+0.57)
11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015
at The Street - Fri Jan 02, 1:43PM CST
Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.
ACHC: 63.20 (-0.45), SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), USPH: 41.08 (+0.07), ATRI: 332.77 (-2.85), STE: 65.50 (-0.35), GB: 50.86 (+0.20), TFX: 112.07 (+0.47), ICLR: 60.01 (+0.38), CMN: 44.28 (+1.09), UTMD: 58.02 (-0.40)
West Pharmaceutical Services Up 27.8% Since SmarTrend Uptrend Call (WST)
Comtex SmarTrend(R) - Mon Dec 29, 9:46AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 4 months, West Pharmaceutical Services has returned 27.76% as of today's recent price of $54.26.
WST: 51.35 (+0.57)
West Pharmaceutical declares $0.11 dividend
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 11:34AM CST
WST: 51.35 (+0.57)
CORRECTION - West Announces Quarterly Dividend
Marketwired - Mon Dec 22, 11:11AM CST
In the news release issued Friday, December 19, 2014 by West Pharmaceutical Services, Inc. (NYSE: WST), we are advised by the company that the originally issued headline was incorrect. Complete corrected text follows.
WST: 51.35 (+0.57)
West Pharmaceutical Services Has Returned 28.9% Since SmarTrend Recommendation (WST)
Comtex SmarTrend(R) - Mon Dec 22, 9:15AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 4 months, West Pharmaceutical Services has returned 28.94% as of today's recent price of $54.76.
WST: 51.35 (+0.57)
West reports hike of 10% in quarterly dividend
M2 - Mon Dec 22, 5:52AM CST
The board of directors of West Pharmaceutical Services (NYSE:WST), a healthcare company, declared on Friday its dividend of USD0.11 per share for the Q1 2015.
WST: 51.35 (+0.57)
West Announces 10% Increase in Quarterly Dividend
Marketwired - Fri Dec 19, 3:30PM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2015 dividend of $0.11 per share. The dividend will be paid on February 4, 2015 to shareholders of record as of January 21, 2015.
WST: 51.35 (+0.57)
Shares of WST Up 25.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 12, 4:48PM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 4 months, West Pharmaceutical Services has returned 25.62% as of today's recent price of $53.35.
WST: 51.35 (+0.57)
Dividend Contenders, Future Champions Or Future Failures: Part 9
Stan Stafford - at Seeking Alpha - Thu Dec 11, 8:26PM CST
WST: 51.35 (+0.57), ATRI: 332.77 (-2.85), MLAB: 73.79 (-1.37)
Why Are These Four Stock Groups On The Rise?
at Investor's Business Daily - Wed Dec 10, 10:36AM CST
Momentum can shift quickly on Wall Street. A single trend or event sends some stocks or industries tumbling, while others get a shot in the arm and race higher. Stock groups that fall into the latter category -- share prices that have spiked...
FDX: 176.47 (+0.17), WST: 51.35 (+0.57), BDX: 143.71 (+0.72), PDCO: 50.65 (-0.16), DIS: 104.17 (+0.59), AIRT: 19.45 (+0.39), UPS: 101.79 (+0.38), TWX: 83.87 (+0.56), NFLX: 466.10 (+9.37), WHR: 213.23 (+0.18), AAWW: 48.01 (+0.44), VIA: 69.08 (+1.02), NWL: 39.57 (+0.32), CFN: 59.81 (+0.01), MIDD: 105.62 (+1.51), FOXA: 34.72 (+0.31), CBS: 59.83 (+2.06)
Eternity Healthcare receives US FDA's approval for NovaGuard SA for safer administration of vaccines
M2 - Wed Dec 10, 6:22AM CST
Medical diagnostic company Eternity Healthcare (Other OTC:ETAH) reported on Tuesday the receipt of the Food and Drug Administration's (FDA) 510(K) clearance to start producing Needle-stick Guards to help the medical professionals administer vaccines in a safer way.
WST: 51.35 (+0.57)
FDA Approves a Safer Way to Administer Vaccines
GlobeNewswire - Tue Dec 09, 8:11AM CST
Eternity Healthcare Inc. (OTC:ETAH), a medical device and diagnostic company with advanced technologies in Needle-Free Injection system, announced today that the Food and Drug Administration (FDA) has given 510(K) clearance to West Pharmaceutical Services, Inc. to start producing Needle-stick Guards to help the Medical Professionals administer vaccines in a safer way.
WST: 51.35 (+0.57)
